Related Experiment Video
Updated: Feb 21, 2026
Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
Published on: July 6, 2013
[Advances in tumor-therapy using genetically modified Salmonella]
Kang Liang1, Xinxin Zhao1, Jie Yi1
1Institute of Preventive Veterinary Medicine, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Abstract:
Tumor is a neoplasm formed by the abnormal proliferation of local tissue cells under the effects of different tumorigenic factors. Tumor-therapy has always been a difficult clinical issue, while regular cancer treatments, such as radiotherapy, chemotherapy and surgery, have obvious limitations. Earlier studies have shown that some obligate anaerobes or facultative anaerobes have anti-tumor effects, for example, Salmonella typhymurium as facultative anaerobic bacteria can selectively colonize tumors and inhibit their growth. Besides, Salmonella has many advantages in tumor-therapy. In the past decade or two, many researchers have carried out genetic manipulation to attenuate the virulence of Salmonella, to improve their specificity of tumor colonization and specially to use attenuated Salmonella as carriers to deliver a variety of anti-tumor therapeutic molecules, and these genetically modified Salmonella have shown good anti-tumor effects in many animal experiments. Along with further research of Salmonella-mediated antitumor treatment, applications of genetically modified Salmonella for more effective tumor-therapy are promising. We reviewed the anti-tumor mechanisms of Salmonella, the research progress in tumor-therapy using genetically modified Salmonella, and current problems and possible solutions.
Insights
Genetically modified Salmonella bacteria show promise for tumor therapy by selectively targeting and inhibiting tumor growth. These engineered bacteria offer a novel approach to cancer treatment, overcoming limitations of traditional methods.
Area of Science:
- Oncology
- Microbiology
- Biotechnology
Background:
- Tumorigenesis involves abnormal cell proliferation, posing significant clinical challenges.
- Conventional cancer treatments like radiotherapy, chemotherapy, and surgery have notable limitations.
- Certain anaerobic bacteria, including Salmonella typhimurium, exhibit anti-tumor properties and can selectively colonize tumors.
Purpose of the Study:
- To review the anti-tumor mechanisms of Salmonella.
- To summarize research progress in genetically modified Salmonella for tumor therapy.
- To discuss current challenges and potential solutions in Salmonella-mediated tumor treatment.
Main Methods:
- Review of existing literature on Salmonella and its anti-tumor applications.
- Analysis of genetic modifications in Salmonella to enhance tumor specificity and therapeutic delivery.
- Evaluation of experimental data from animal models using engineered Salmonella.
Main Results:
- Attenuated Salmonella strains demonstrate selective tumor colonization and growth inhibition.
- Genetically modified Salmonella serve as effective carriers for anti-tumor therapeutic molecules.
- Numerous animal experiments show promising anti-tumor effects of engineered Salmonella.
Conclusions:
- Genetically modified Salmonella offer a promising avenue for advanced tumor therapy.
- Further research into Salmonella-mediated treatments could lead to more effective cancer interventions.
- Addressing current challenges will be crucial for the clinical application of these engineered bacteria.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Tumor Immunotherapy
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...